OneStep, an innovative health tech startup, has successfully raised $36 million in a Series B funding round led by Team8 and Vintage Investment Partners, with contributions from existing investors such as Aleph, 10D, and LionBird. This recent funding brings the total investment in the company to $48 million since its founding in late 2019. OneStep's mission is to establish gait analysis as the sixth vital sign, crucial for improving overall health monitoring, particularly in an aging population.

Revolutionizing Motion Analysis

OneStep has developed a groundbreaking smartphone-based technology that transforms everyday devices into clinical-grade motion analysis tools. This technology simplifies the process of gait analysis, allowing it to be as quick and effortless as stepping onto a bathroom scale. By capturing and analyzing movement data through smartphones, healthcare providers can obtain valuable insights into their patients' mobility and overall health, facilitating timely interventions and enhancing patient engagement.

Gait analysis is increasingly recognized as an important indicator of health, particularly for chronic conditions affecting mobility. The ability to measure gait quickly and easily opens up new avenues for early detection of potential health issues, such as falls, Parkinson's disease, and Alzheimer's disease. Through proactive monitoring, healthcare professionals can implement interventions that significantly enhance quality of life.

The Importance of Gait Analysis in Healthcare

As life expectancy increases, so does the prevalence of chronic conditions that impact mobility and gait. Traditional gait analysis methods are often limited to specialized laboratories equipped with expensive technology, making the assessment cumbersome and inaccessible for many patients. OneStep aims to address these challenges by bringing gait analysis into the everyday lives of individuals.

OneStep's FDA-listed platform leverages artificial intelligence to provide continuous, real-time monitoring of patient mobility. This enables healthcare providers to make informed decisions based on objective data, ultimately improving patient outcomes. Key features of OneStep's platform include the ability to detect early signs of deterioration in patient health, streamline documentation processes, and reduce healthcare costs associated with falls and mobility-related complications.

Aiming for a Healthier Future

The recent funding will allow OneStep to scale its operations, enhance its technology, and promote the adoption of gait analysis as a routine part of health monitoring. According to Tomer Shussman, co-founder and CEO of OneStep, the vision is for gait measurement to become a daily activity, similar to weighing oneself in the morning. This shift would empower individuals to take charge of their health by providing ongoing insights into their mobility.

By improving recovery times for patients and reducing the risk of falls among the elderly, OneStep's technology has already made a significant impact in the rehabilitation sector. In fact, patients using the platform recover 45% faster, and the risk of falls in older adults decreases by 20%. Furthermore, healthcare providers can benefit financially through new revenue streams generated by Remote Therapeutic Monitoring (RTM) capabilities.

Expanding the Horizon of Health Monitoring

OneStep's founders, who are graduates of the IDF’s Talpiot program, envisioned a solution that harnesses the capabilities of smartphones for continuous medical monitoring. Currently employing around 50 people, OneStep has established a development center in Tel Aviv while maintaining operations in the United States. The company has recently expanded its focus to include cognitive monitoring, addressing conditions such as Alzheimer's and Parkinson's disease.

The potential for OneStep’s technology extends beyond rehabilitation; it holds promise for a range of healthcare applications. With 1 in 4 individuals estimated to require continuous gait monitoring in the future, the importance of establishing gait analysis as a vital sign is more pressing than ever.

OneStep is at the forefront of a transformative movement in healthcare, where gait analysis is poised to become a fundamental component of routine health assessments. With its innovative technology and the recent influx of funding, OneStep is well-positioned to make significant strides in enhancing patient care and empowering healthcare providers. As the company works to establish gait analysis as the sixth vital sign, it not only aims to improve individual health outcomes but also seeks to redefine the standards of health monitoring in a rapidly evolving healthcare landscape.